The scientist’s investigation covers issues in Psychiatry, Clinical psychology, Mental health, Schizophrenia and Depression. His work on Mental illness, Substance abuse, Comorbidity and Antipsychotic as part of general Psychiatry study is frequently connected to Suicide prevention, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Antipsychotic research is multidisciplinary, incorporating elements of Quetiapine, Olanzapine and Psychosocial.
In general Clinical psychology study, his work on Psychopathology often relates to the realm of Disease cluster, thereby connecting several areas of interest. The various areas that Marvin S. Swartz examines in his Schizophrenia study include Psychosis and Social environment. His Depression research includes themes of Odds ratio and Anxiety.
His main research concerns Psychiatry, Mental health, Mental illness, Clinical psychology and Schizophrenia. His work in the fields of Psychiatry, such as Substance abuse, Antipsychotic and Outpatient commitment, intersects with other areas such as Suicide prevention. His work carried out in the field of Antipsychotic brings together such families of science as Quetiapine, Risperidone, Internal medicine and Olanzapine.
His research in Mental health intersects with topics in Psychological intervention, Nursing, Public health and Social environment. His research integrates issues of Schizophrenia, Comorbidity, Depression and Quality of life in his study of Clinical psychology. His biological study spans a wide range of topics, including Neurocognitive and Psychosis.
Marvin S. Swartz mainly investigates Psychiatry, Mental illness, Mental health, Suicide prevention and Injury prevention. Marvin S. Swartz interconnects Criminal justice and Clinical psychology in the investigation of issues within Psychiatry. His studies deal with areas such as Schizophrenia and Drug as well as Clinical psychology.
The Mental illness study combines topics in areas such as Bipolar disorder, Recidivism and Schizophrenia. His Assertive community treatment study in the realm of Mental health connects with subjects such as Work. His biological study spans a wide range of topics, including Quetiapine, Risperidone, Olanzapine and Perphenazine.
Marvin S. Swartz spends much of his time researching Psychiatry, Injury prevention, Mental illness, Suicide prevention and Occupational safety and health. Marvin S. Swartz incorporates Psychiatry and Context in his studies. His Mental illness research includes themes of Bipolar disorder and Clinical psychology.
His Bipolar disorder research incorporates elements of Methadone, Schizophrenia and Pharmacotherapy. His Substance abuse research is multidisciplinary, incorporating elements of Medical prescription, Major depressive episode and Heroin. His Medical emergency study integrates concerns from other disciplines, such as Mental health, Criminology and Adjudication.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Jeffrey A. Lieberman;T. Scott Stroup;Joseph Patrick McEvoy;Joseph Patrick McEvoy;Marvin S. Swartz.
The New England Journal of Medicine (2005)
Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence
Ronald C. Kessler;Katherine A. McGonagle;Marvin Swartz;Dan G. Blazer.
Journal of Affective Disorders (1993)
The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey.
Dan G. Blazer;Ronald C. Kessler;Katherine A. McGonagle;Marvin S. Swartz.
American Journal of Psychiatry (1994)
Comorbidity of DSM–III–R Major Depressive Disorder in the General Population: Results from the US National Comorbidity Survey
Kessler Rc;Nelson Cb;McGonagle Ka;Liu J.
The British journal of psychiatry. Supplement (1996)
Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial
Richard S.E. Keefe;Robert M. Bilder;Sonia M. Davis;Philip D. Harvey.
Archives of General Psychiatry (2007)
Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment
Joseph Patrick McEvoy;Jeffrey A. Lieberman;T. Scott Stroup;Sonia M. Davis.
American Journal of Psychiatry (2006)
Prevalence, correlates, and course of minor depression and major depression in the national comorbidity survey
Ronald C Kessler;Ronald C Kessler;Shanyang Zhao;Dan G Blazer;Marvin Swartz.
Journal of Affective Disorders (1997)
Violence and severe mental illness: the effects of substance abuse and nonadherence to medication.
M. S. Swartz;Jeffrey W. Swanson;V. A. Hiday;Randy Borum.
American Journal of Psychiatry (1998)
A National Study of Violent Behavior in Persons With Schizophrenia
Jeffrey W. Swanson;Marvin S. Swartz;Richard A. Van Dorn;Eric B. Elbogen.
Archives of General Psychiatry (2006)
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.
Stanley D. Rosenberg;Lisa A. Goodman;Fred C. Osher;Marvin S. Swartz.
American Journal of Public Health (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: